A Phase III Study for Patients With Metastatic Hormone-naïve Prostate Cancer

NCT01957436 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

1173

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Prostate Cancer

Interventions

DRUG: abiraterone acetate
RADIATION: radiotherapy
OTHER: Androgen Deprivation Therapy
DRUG: Docetaxel

Sponsor

UNICANCER

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]